Abstract

Specific transcripts for bile salt-dependent lipase (BSDL), a 100-kDa glycoprotein secreted by the human pancreas, were immunodetected in BxPC-3 and SOJ-6 pancreatic tumoral cell lines. Sequencing of fragments, obtained by mRNA reverse transcription and amplification, confirmed the presence of BSDL transcripts in these cancer cells. The protein was detected in lysates of pancreatic tumoral cells, where it was mainly associated with membranes. Only a minute amount of the enzyme was detected in the culture media. Immunofluorescence studies demonstrated that in SOJ-6 cells, BSDL colocates with the p58 Golgi protein and suggested that the protein may be sequestrated within the Golgi compartment. These results demonstrated that BSDL is expressed in human pancreatic tumoral cells and cannot be secreted (or for the least very poorly). Subsequently, a cDNA covering the entire sequence of BSDL was obtained by reverse transcription-polymerase chain reaction. The sequence of this cDNA indicated that the N-terminal domain encoded by exons 1-10 was identical to that of BSDL expressed by the human normal pancreas. However, the sequence corresponding to exon 11, which should code for the 16 tandem-repeated identical mucin-like sequences of BSDL, was deleted by 330 base pairs (bp) and encoded only 6 of these repeated sequences. We conclude that this truncated variant of BSDL would be its oncofetal form, referred to as feto-acinar pancreatic protein. We then investigated whether the deletion of 330 bp affected the secretion of the protein. For this purpose, the cDNA corresponding to the mature form of the BSDL variant expressed in SOJ-6 cells was cloned into an expression/secretion vector and transfected into CHO-K1 cells. Results indicated that the variant of BSDL isolated from SOJ-6 cells was expressed and secreted by transfected cells. However, the level of BSDL secreted by these transfected CHO-K1 cells was significantly higher than that observed for SOJ-6 cells. Consequently, the retention of the oncofetal variant of BSDL observed in human pancreatic tumoral cells might not result from inherent properties of the protein.

Highlights

  • The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF081673

  • A negative reaction was found when RNA was hybridized with the ␣-amylase probe, whereas that of bile salt-dependent lipase (BSDL) detected a specific transcript in tumoral cell lines (Fig. 1)

  • BSDL and ␣-amylase transcripts were detected in normal adult pancreas, whereas transcript encoding BSDL was only detected in tumoral pancreas; values were similar to those found with cancer cells

Read more

Summary

Introduction

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF081673. It has been suggested that the interaction of BSDL with the Grp94-related p94 protein is essential for the O-glycosylation of C-terminal tandem-repeated sequences (9). These repeated sequences contain PEST regions, which are signals for rapid degradation (10). Other studies have shown that FAPP is expressed in pancreatic tumor cells; the secretion of the protein was not detected (21). We showed that part of C-terminal tandem repeated sequences were deleted in the BSDL variant expressed by pancreatic tumoral cells, suggesting that we are dealing with FAPP. CHO-K1 cells transfected with the truncated cDNA secreted the protein This result indicates that the retention of FAPP within tumor cells cannot be due to the truncation of the C-terminal region of the protein

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call